144 related articles for article (PubMed ID: 12889851)
21. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
[TBL] [Abstract][Full Text] [Related]
22. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
[TBL] [Abstract][Full Text] [Related]
23. Gastric motility in patients with recurrent gastric ulcers.
Kamiya T; Kobayashi Y; Hirako M; Misu N; Nagao T; Hara M; Matsuhisa E; Ando T; Adachi H; Sakuma N; Kimura G
J Smooth Muscle Res; 2002 Apr; 38(1-2):1-9. PubMed ID: 12199528
[TBL] [Abstract][Full Text] [Related]
24. Proton-pump inhibitor-refractory gastric ulcer and Helicobacter pylori.
Arakawa T; Kimura S; Uchida T; Higuchi K; Fukuda T; Kobayashi K
Am J Gastroenterol; 1993 Aug; 88(8):1295. PubMed ID: 8338112
[No Abstract] [Full Text] [Related]
25. Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
Sou Y; Saita H; Takahashi Y; Yoshinaga T; Matsukawa Y; Sekikawa A; Nakazawa T; Shio S; Kohigashi K
J Gastroenterol; 1999; 34 Suppl 11():84-90. PubMed ID: 10616773
[TBL] [Abstract][Full Text] [Related]
26. Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori.
Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():229-34. PubMed ID: 11966546
[TBL] [Abstract][Full Text] [Related]
27. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
Ashida K; Sakaguchi M; Tanaka M; Takiuchi H; Egashira Y; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S67-71. PubMed ID: 7594345
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T
J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
[TBL] [Abstract][Full Text] [Related]
29. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
30. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
Lai YC; Wang TH; Huang SH; Yang SS; Wu CH; Chen TK; Lee CL
World J Gastroenterol; 2003 Jul; 9(7):1537-40. PubMed ID: 12854158
[TBL] [Abstract][Full Text] [Related]
31. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
32. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
33. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
[TBL] [Abstract][Full Text] [Related]
34. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
[TBL] [Abstract][Full Text] [Related]
35. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
36. In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Yukselen V; Yasa MH; Karaoglu AO
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccvi-cccviii. PubMed ID: 15244210
[TBL] [Abstract][Full Text] [Related]
37. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T
J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
[TBL] [Abstract][Full Text] [Related]
39. Lansoprazole and Helicobacter pylori infection.
Pallone F; Luzza F; Delle Fave G; Annibale B; Marcheggiano A; Biancone L; Torsoli A; Capurso L
Clin Ther; 1993; 15 Suppl B():49-57. PubMed ID: 8205595
[TBL] [Abstract][Full Text] [Related]
40. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
